subject_line
Mantle Cell Lymphoma Video Evaluation
1. Please select the option that best describes you:
*
Patient
Caregiver
Family Member
Friend/Concerned Individual
Healthcare Professional
Community Member
Other (please describe)
Other (please describe)
Please select subcategory
*
Parent
Child
Sibling
Spouse/Partner/Significant Other
Extended Family Member
Other
Other
Please select subcategory
*
Physician
PCP
Nurse
NP
PA
Pharmacist
Medical Assistant
Pharmaceutical Rep
Radiation Tech
Psychologist
Social Worker
Hospital/Homebound Teacher
Other HCP
Other HCP
1a. What is your year of birth?
*
Prefer not to disclose
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
1967
1966
1965
1964
1963
1962
1961
1960
1959
1958
1957
1956
1955
1954
1953
1952
1951
1950
1949
1948
1947
1946
1945
1944
1943
1942
1941
1940
1939
1938
1937
1936
1935
1934
1933
1932
1931
1930
1929
1928
1927
1926
1925
1924
1923
1922
1921
1920
1919
1918
1917
1916
1915
I verify that I am older than 18 years of age. LLS cannot correspond with minors without parental consent.
2. Do you describe yourself as a man, a woman, or in some other way?
*
Man
Woman
Prefer not to disclose
Some other way, please specify
Some other way, please specify
3. What is your ZIP code or postal code?
*
4. What is your Race? (check
all
that apply)
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiian or Pacific Islander
White or Caucasian
Prefer not to disclose
Other (please specify)
Other (please specify)
Are you Hispanic/Latino?
Yes
No
Prefer not to disclose
5. Have you or the patient been diagnosed with a blood cancer?
*
N/A
Yes
No
If
no
, please tell us the type of cancer with which you/patient were diagnosed:
*
If
yes
, when were you/patient diagnosed?
Month
*
January
February
March
April
May
June
July
August
September
October
November
December
Day
*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
*
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
1967
1966
1965
1964
1963
1962
1961
1960
1959
1958
1957
1956
1955
1954
1953
1952
1951
1950
1949
1948
1947
1946
1945
1944
1943
1942
1941
1940
1939
1938
1937
1936
1935
1934
1933
1932
1931
1930
1929
1928
1927
1926
1925
1924
1923
1922
1921
1920
1919
1918
1917
1916
1915
Check if approximate date
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
1967
1966
1965
1964
1963
1962
1961
1960
1959
1958
1957
1956
1955
1954
1953
1952
1951
1950
1949
1948
1947
1946
1945
1944
1943
1942
1941
1940
1939
1938
1937
1936
1935
1934
1933
1932
1931
1930
1929
1928
1927
1926
1925
1924
1923
1922
1921
1920
1919
1918
1917
1916
1915
Check if approximate date
If
yes
, please tell us what type of blood cancer (check
all
that apply):
*
Mantle cell lymphoma (MCL)
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Chronic lymphocytic leukemia (CLL)
Chronic myeloid leukemia (CML)
Hodgkin lymphoma (HL)
Non-Hodgkin lymphoma (NHL)
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)
Myeloproliferative neoplasms (MPN) (polycythemia vera, essential thrombocythemia, myelofibrosis)
Other (please specify)
Other (please specify)
Are you or the patient currently being treated?
*
Yes
No
What treatments have you or the patient had? (check
all
that apply)
*
Combination drug therapy (chemotherapy)
Allogeneic Stem Cell Transplantation
Autologous Stem Cell Transplantation
Bisphosphonates
CAR T-cell therapy
Immunotherapy
Radiation therapy
Single drug therapy (oral medication or IV)
Tyrosine kinase inhibitor (TKI)
Watch and Wait
N/A
Other (please specify)
Other (please specify)
6. Are you or the patient presently in or ever participated in a clinical trial?
*
N/A
Yes
No
7. How effective was Jacob D. Soumerai, MD, in explaining:
*
Not Effective
Somewhat Effective
Effective
Very Effective
What Mantle Cell Lymphoma (MCL) is and how it is diagnosed
Not Effective
Somewhat Effective
Effective
Very Effective
The history of MCL treatments
Not Effective
Somewhat Effective
Effective
Very Effective
The future of MCL treatments
Not Effective
Somewhat Effective
Effective
Very Effective
8. Following this program, do you feel more prepared to discuss cancer diagnoses challenges with a healthcare professional?
*
N/A
Yes
No
Please explain how:
9. Please describe any information you expected to get from this program but did not receive.
10. Please give us any additional feedback about this program.
Thank you for your comments.
If you would like more information from LLS, please provide your contact information below:
First Name:
Last Name:
Email Address:
or complete mailing address, including ZIP/postal code:
If you have additional questions following this program, please contact an LLS Information Specialist toll-free at (800) 955-4572 or www.LLS.org/ContactUs
* Indicates required field